Wolfson to test red-grape-derived product on diabetics

Wolfson’s diabetes clinic will examine a new form of reservatrol – a type of natural polyphenol and a phytoalexin.

December 9, 2013 23:06
1 minute read.

Grapes 370. (photo credit: George Medovoy)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The French are known to eat heavy, fatty and sweet meals – along with red wine in moderation – but their general health does not suffer as a result. This French Paradox has challenged researchers, who will now test type II diabetics with a compound derived from red wine grapes, especially their skins, which contain the powerful beneficial chemical, reservatrol.

Dr. Julio Weinstein, director of the diabetes unit at Wolfson Medical Center, Holon and longtime president of the Israel Diabetes Association has decided to launch a “unique study” aimed at discovering whether the red grapes of the French is as effective as the active ingredient of a natural drug for helping diabetes patients.

Be the first to know - Join our Facebook page.

Wolfson’s diabetes clinic will examine a new form of reservatrol – a type of natural polyphenol and a phytoalexin – to see whether it improves the metabolic balance of diabetes patients.

These parameters include not only sugar/insulin balance but also cholesterol, blood pressure and other elements involved in the metabolic syndrome.

Participants will make four clinic visits, and undergo treatment for thee months.

Those who control their blood sugar with only diet and oral medications, and not with injectable insulin, are invited to participate in the study – they can call (03) 502-8329 for more information.

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice